Organization
Anterogen
14 clinical trials
Clinical trial
Double Blind, Randomized, Phase II Clinical Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET Versus Vehicle Control in Dystrophic Epidermolysis Bullosa (DEB) PatientsStatus: Recruiting, Estimated PCD: 2025-10-01
Clinical trial
A Phase 2 Clinical Study to Evaluate The Efficacy and Safety of ALLO-ASC-SHEET in the Subjects With Diabetic Wagner Grade II Foot UlcersStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Phase 3 Clinical Study to Evaluate Efficacy and Safety of ASC(Autologous Adipose-derived Stem Cells) and Fibringlue or Fibringlue in Patients With Crohn's Fistula.: A Randomized StudyStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Phase 3 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers: A Randomized, Comparator-controlled, Double-blind, Parallel-group, Multi-center StudyStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Follow-up Study to Evaluate the Efficacy and Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 1/2 Clinical Trial of ALLO-ASC-EB-101Status: Completed, Estimated PCD: 2018-04-20
Clinical trial
A Phase 1 Clinical Study to Evaluate the Safety of Allogeneic Adipose-derived Stem Cells in the Subjects With Crohn's DiseaseStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 2 Clinical Trial of ALLO-ASC-DFU-201Status: Completed, Estimated PCD: 2018-08-17
Clinical trial
Phase 3 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers: A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multi-center StudyStatus: Completed, Estimated PCD: 2019-12-09
Clinical trial
A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 3 Clinical Trial of ALLO-ASC-DFU-301Status: Completed, Estimated PCD: 2021-09-30
Clinical trial
Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in the Subjects With Crohn´s Disease(ALLO-ASC-CD-101)Status: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 2 Clinical Trial of ALLO-ASC-BI-201Status: Completed, Estimated PCD: 2020-04-02
Clinical trial
Phase I Study of Dose Escalation of Human Allogenic Adipose-derived Stem Cells (ALLO-ASC) to Evaluate Safety and Efficacy in Patients With Crohn's FistulaStatus: Completed, Estimated PCD: 2012-10-11
Clinical trial
A Phase II Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects: Controlled, Parallel, MulticenterStatus: Completed, Estimated PCD: 2019-07-02
Clinical trial
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical TrialStatus: Recruiting, Estimated PCD: 2025-12-31